"Designing Growth Strategies is in our DNA"

Injectable Reproductive Hormone Market Size, Share & Industry Analysis, By Type (Estrogen, Progesterone, Testosterone, Combination Products), By Applications (Infertility Treatment, Contraception, Menstruation Disorders, Sexual Dysfunction, Others), By End users (Hospitals, Specialty clinics, Others) Pfizer, Xianju Pharma, American Regent, Zydus Cadila, Actiza Pharmaceutical, Empower Pharmacy,Others and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI102051 | Status : Ongoing

 

KEY MARKET INSIGHTS

Reproductive Hormone refers to a hormone that is involved in fertility and sexuality. These reproductive hormones are usually made in the testes and ovaries in male and female reproductive system respectively. Wherein, female reproductive hormones consist of progesterone and estrogen and male reproductive hormone include testosterone which in developing and maintaining sex characteristics of both female and male. They play major role in female characteristics such as fertility, pregnancy, and menstrual cycle. Where as in male they help in formation of sperms in the testes. These reproductive hormones can be formed in laboratory and used to for the treatment of various medical conditions. Furthermore, they are also used for the treatment, prevention, improvement of disease, symptoms, and conditions which include vasomotor symptoms associated with menopause, vaginal and vulvar atrophy associated with hypoestrogenism, hypogonadism, ovarian failure, and others is also triggering the growth of the market.


Key Market Driver -

Rise in adoption of injectable reproductive hormone.

Key Market Restraint -

Stringent regulations.


Rise in adoption of injectable hormones for normal reproductive functioning, rise in innovative products for reproductive injectable, growing awareness related to sexual health and reproductive, treatment of prostate cancer, are the major factors driving growth of the market during forecast period. According to World Cancer report, cancer cases will be increasing by 50% to 15 million new cases by 2020 which is also anticipated to positively influence the market growth. Furthermore, use of estrogen to treat symptoms of menopause which include vaginal dryness, hot flashes, burning, irritation, and others is also influencing the growth of the market in near future. It is also used in treatment of lack of estrogen that occurs due to ovarian failure called as hypogonadism which is boosting the growth of the market. Additionally, these injectable hormones also help in birth controlling by progestin and an estrogen combination of these invectives helps in preventing pregnancy. For instance, the injections by name Cyclofem and Mesigyna consists of synthetic forms of the estrogen and progestin hormones formed by the body which destroy pituitary gland and stops ovaries from liberating eggs leading to prevention of pregnancies. These injections can also change the uterus lining and mucus in your cervix which makes difficult for sperms to reach eggs. Thus Estrogen and progestin hormonal injections are highly effective in prevention of pregnancy which is significantly influencing the growth of the market.


However, lack of skilled professionals, lack of technology penetration, stringent regulations, side effects due to these injectable are hampering the growth of market during the forecast period. For instance, Estrogen rises the risk that leads to occurrence of endometrial cancer, omitting, weight gain or loss, dizziness, nervousness, depression, irritability, and others. These hormones also effect eating habits such as Progesterone increases the food intake, Testosterone also Stimulates food intake, and others.


Market Segmentation:


Globally, the injectable reproductive hormone market is segmented on bases of product type, estrogen, progesterone, and testosterone. Based on the applications, the market is segmented into infertility treatment, contraception’s, menstruation disorders, sexual dysfunction, and others. Based on the end users, the market is classified into hospitals, specialty clinics, and others.


Geographically, the global Injectable Reproductive Hormone market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.


Key Players Covered:


The major companies in the global injectable reproductive hormone market include  Pfizer, Xianju Pharma, American Regent, Zydus Cadila, Actiza Pharmaceutical, Empower Pharmacy, ABBVIE, Bayer, Endo Pharmaceuticals, Mayne Pharma, Allergan and others.


Key Insights:



  • Pipeline Analysis, Key Players

  • New Product Launches

  • Key Industry Developments

  • Pricing Analysis


Regional Analysis:


To gain extensive insights into the market, Request for Customization


Geographically, the global injectable reproductive hormone market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the market owing technological advancements, huge investment in the healthcare industry, and the quick adoption of technology. Europe is the second-largest contributor to the market owing to an increase in health care awareness, increased capita income expenditure, increased healthcare infrastructure. Asia Pacific is anticipated to experience vast growth in the market owing to rise in geriatric population, an increase in healthcare awareness, and an increase in government initiatives towards the healthcare sector, and an increase in the number of research activities, and others. Latin America and Middle East are also anticipated to experience lucrative growth in the market.


Segmentation


























 ATTRIBUTE


 DETAILS

By  Type




  • Estrogen

  • Progesterone

  • Testosterone

  • Combination Products



By Applications




  • Infertility Treatment

  • Contraception

  • Menstruation Disorders

  • Sexual Dysfunction

  • Others



By End users




  • Hospitals

  • Specialty clinics

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)



Injectable Reproductive Hormone Industry Developments



  • In October 2018, FDA approved testosterone self-injection for hypogonadism in men with primary hypogonadism or hypogonadotropic hypogonadism.


Injectable Reproductive Hormone Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Amgen
Johnson
uniliver
Fresenius
Styker

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X